Source: Hematology, Transfusion and Cell Therapy. Unidade: FMRP
Subjects: IMUNOTERAPIA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, Gil Cunha et al. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V. Special article: manufacture and quality control. Hematology, Transfusion and Cell Therapy, v. 43, n. S2, p. S35-S41, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2021.09.005. Acesso em: 29 jan. 2026.APA
De Santis, G. C., Langhi Junior, D. M., Feitoza, A., Mendrone Junior, A., Kutner, J. M., Covas, D. T., et al. (2021). Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V. Special article: manufacture and quality control. Hematology, Transfusion and Cell Therapy, 43( S2), S35-S41. doi:10.1016/j.htct.2021.09.005NLM
De Santis GC, Langhi Junior DM, Feitoza A, Mendrone Junior A, Kutner JM, Covas DT, Couto SCF, Guerino-Cunha RL, Orellana MD, Rizzo SRCP. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V. Special article: manufacture and quality control [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( S2): S35-S41.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.htct.2021.09.005Vancouver
De Santis GC, Langhi Junior DM, Feitoza A, Mendrone Junior A, Kutner JM, Covas DT, Couto SCF, Guerino-Cunha RL, Orellana MD, Rizzo SRCP. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V. Special article: manufacture and quality control [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( S2): S35-S41.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.htct.2021.09.005
